174
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement

, , , , , , , & show all
Pages 201-210 | Published online: 06 Jun 2008

References

  • BammerRSkareSNewbouldRFoundations of advanced magnetic resonance imagingNeuroRx200521679615897944
  • BellinMFMR contrast agents, the old and the newEur J Radiol2006603142317005349
  • BryantLHJrBrechbielMWWuCSynthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelatesJ Magn Reson Imaging199993485210077036
  • HilgenbrinkARLowPSFolate receptor-mediated drug targeting: from therapeutics to diagnosticsJ Pharm Sci20059421354616136558
  • KalliKRObergALKeeneyGLFolate receptor alpha as a tumor target in epithelial ovarian cancerGynecol Oncol20081086192618222534
  • KobayashiHBrechbielMWNano-sized MRI contrast agents with dendrimer coresAdv Drug Deliv Rev20055722718616290152
  • KobayashiHKawamotoSSakaiYLymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agentJ Nal Cancer Inst2004967038
  • KondaSDArefMWangSSpecific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenograftsMagma2001121041311390265
  • KondaSDWangSBrechbielMBiodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenograftsInvest Radiol20023719920411923642
  • Kukowska-LatalloJFCandidoKACaoZNanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancerCancer Res20056553172415958579
  • LausSSourARuloffRRotational dynamics account for pH-dependent relaxivities of PAMAM dendrimeric, Gd-based potential MRI contrast agentsChemistry20051130647615776490
  • LeachMOBrindleKMEvelhochJLAssessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsBr J Radiol200376Spec No 1S879115456718
  • LogothetisNKPfeufferJOn the nature of the BOLD fMRI contrast mechanismMagn Reson Imaging20042215173115707801
  • MasseyFJThe Kolmogorov-Smirnov Test for Goodness of FitJ Am Stat Assoc1951466878
  • MathiasCJLewisMRReichertDEPreparation of Ga-66- and Ga-68-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticalsNucl Med Biol2003307253114499330
  • MathiasCJWangSWatersDJIndium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceuticalJ Nucl Med1998391579859744347
  • NagarajaTNCroxenRLPandaSApplication of arsenazo III in the preparation and characterization of an albumin-linked, gadolinium-based macromolecular magnetic resonance contrast agentJ Neurosci Methods20061572384516769125
  • NasongklaNBeyERenJMMultifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systemsNano Letters2006624273017090068
  • NicolleGMTothESchmitt-WillichHThe impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agentChemistry200281040811891890
  • ParkerNTurkMJWestrickEFolate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assayAnal Biochem20053382849315745749
  • PatriAKKukowska-LatalloJFBakerJRJrTargeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complexAdv Drug Deliv Rev20055722031416290254
  • PatriAKMajorosIJBakerJRDendritic polymer macromolecular carriers for drug deliveryCurr Opin Chem Biol200264667112133722
  • QuintanaARaczkaEPiehlerLDesign and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptorPharm Res2002191310612403067
  • RudovskyJBottaMHermannPPAMAM dendrimeric conjugates with a Gd-DOTA phosphinate derivative and their adducts with polyaminoacids: the interplay of global motion, internal rotation, and fast water exchangeBioconjug Chem2006179758716848405
  • ShellockFGKanalESafety of magnetic resonance imaging contrast agentsJ Magn Reson Imaging1999104778410508312
  • SwansonSDRosenMSAgranoffBWBrain MRI with laser-polarized 129XeMagn Reson Med19973869589358441
  • SwansonSDRosenMSCoulterKPDistribution and dynamics of laser-polarized (129)Xe magnetization in vivoMagn Reson Med19994211374510571936
  • TalanovVSReginoCASKobayashiHDendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imagingNano Letters2006614596316834429
  • ThomasTPMajorosIJKotlyarATargeting and inhibition of cell growth by an engineered dendritic nanodeviceJ Med Chem20054837293515916424
  • van BuchemMAToftsPSMagnetization transfer imagingNeuroimaging Clin N Am20001077188ix11359724
  • VendittoVJReginoCABrechbielMWPAMAM dendrimer based macromolecules as improved contrast agentsMol Pharm200523021116053333
  • WienerECBrechbielMWBrothersHDendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agentsMagn Reson Med199431188121264